A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer

Martinus A. Beek*, Paul D. Gobardhan, Elisabeth G. Klompenhouwer, Marian B. Menke-Pluijmers, Pascal Steenvoorde, Jos W. S. Merkus, Harm J. T. Rutten, Adri C. Voogd, Ernest J. T. Luiten

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalEuropean Journal of Surgical Oncology
Volume46
Issue number1
DOIs
Publication statusPublished - Jan 2020

Keywords

  • Breast cancer
  • Axillary lymph node dissection
  • Lymphedema
  • Axillary reverse mapping
  • LYMPH-NODE DISSECTION
  • QUALITY-OF-LIFE
  • SENTINEL NODE
  • NEOADJUVANT THERAPY
  • MULTICENTER
  • MORBIDITY
  • SURGERY
  • WOMEN

Cite this